New sunscreen protects against both UVA and UVB rays

NewsGuard 100/100 Score

People will now be able to get better protection from the sun with a new sunscreen recently approved by the U.S. Food and Drug Administration (FDA).

The new product, Anthelios SX, made by L'Oreal contains ecamsule (Mexoryl), an agent that shields skin from short-wave UVA rays and provides protection from the full range of both ultraviolet A and B rays, doesn't break down as easily as other products and lasts longer in the sun.

Sunscreens currently available in the United States are unable to do this; the product will be available to consumers in the fall.

However, experts say current advice about avoiding the sun and protecting the skin still applies, and a better sunscreen doesn't change the basic rules of skin protection.

Experts say UVB causes sunburn and skin cancer, while UVA causes aging and some skin cancer; the majority of sunscreens currently available contain two active ingredients: avobenzone and octocrylene.

Anthelios SX, which has an SPF of 15, contains those compounds as well, but adds in Mexoryl.

Sunscreens containing Mexoryl have been available in Europe, Asia and Canada since 1993 and it is unclear why it has taken so long for the FDA to approve the product.

One expert believes the best sun protection combines physical sun blocks with chemical ones, as many sunscreens break down in the sun.

Sun blocks such as zinc oxide and titanium physically block the sun and the ideal sunscreen would block both UVA and UVB, have a high SPF, and would be waterproof.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Triple-negative breast cancer patients with high immune cell levels have lower relapse risk after surgery